ACHN Forecast and Technical Stock Analysis
Sell candidate since 2019-09-18 Loss -1.84% PDF
Achillion Pharmaceuticals fell by -1.06% in the last day ( Friday, 20th Sep 2019 ) from $3.78 to $3.74 and has now fallen 5 days in a row. During the day the stock fluctuated 4.32% from a day low at $3.70 to a day high of $3.86. The price has fallen in 8 of the last 10 days and is down by -12.62% for this period. Volume has increased in the last day by 1.45 million shares but on falling prices. This may be an early warning and the risk will be increased slightly for the next couple of days. In total, 3.07 million shares bought and sold for approximately $11.50 million.
- 30 day high of the ACHN stock price was $4.77 and low was $3.70.
- 90 day high was $5.03 and low was $2.35.
- 52 week high for Achillion Pharmaceuticals - $5.03 and low - $1.29.
Achillion Pharmaceuticals has broken the very wide and strong rising short-term trend down. This signalize a slower rising rate, but may also be an early warning about a possible trend shift. Due to trend being broken there will now be resistance at the bottom line of the trend at $3.78. A reaction back to this level may hold a second chance to get out before further falls.
There are few to none technical positive signals at the moment. Achillion Pharmaceuticals holds sales signals from both short- and long-term moving averages. In addition, there is a general sales signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up there will be some resistance from the lines at $3.87 and $4.36. A break-up above any of these levels will issue buy signals. A sales signal was issued from a pivot top point on Thursday September 05, 2019, which indicates further falls until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.
Relative Strength Index (RSI)
RSImin/max Values: [ 25 - 75 ]
The stock currently holds a RSI14 at 18 and is oversold on RSI14. The stock being oversold is no guarantee for instant reaction up as some stocks may be oversold for a long time. It is important to review the previous RSI-history to get an indication of the RSI-sensitiveness.
* Stockinvest.us uses dynamical calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behaviour.
Support & Resistance
Achillion Pharmaceuticals finds support from accumulated volume at $3.60.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.16 between high and low, or 4.32%. For the last week, the stock has had a daily average volatility of 4.82%.
Achillion Pharmaceuticals is oversold on RSI14 (18). Some stocks may drop long and hard while being oversold on RSI before turning, which increases the general risk.
Our recommended stop-loss: We hold a sell evaluation for this stock. No stop-loss set.
4.82 %Average volatility
Very Low Low Medium High Very High
The Achillion Pharmaceuticals stock holds several negative signals and despite the positive trend we believe Achillion Pharmaceuticals will perform weak in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.
|ACHN $3.74 ($-0.04 -1.06%)|
ACHN is down $0.04 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for ACHN based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the ACHN analysis is free »
Golden Star Signal
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives substantial returns. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!